Your search for ‘McGuireWoods’ returned 3,654 results

In a notice published on Feb. 2, 2012, in the Federal Register, the Centers for Medicare & Medicaid Services (CMS) solicited public comment on the applicability of the Emergency Medical Treatment and Active Labor Act (EMTALA) to inpatients and hospitals with specialized capabilities.

Ranking GOP members of the House of Representatives Committee on Energy and Commerce sent a letter to the Food and Drug Administration.

Congressional lawmakers have reached a bipartisan agreement that would repeal and replace the sustainable growth rate Medicare physician payment formula.

In a November 2009 speech before the Tenth Annual Pharmaceutical Regulatory and Compliance Congress in Washington D.C., Assistant Attorney General Lanny A. Breuer put big pharma on notice that DOJ intended to aggressively investigate potential violations of the FCPA within the pharmaceutical and medical device industry.

On May 1 the U.S. Food and Drug Administration changed the way expert panels analyze whether a medical device should be approved for the general market, hoping a new approach will streamline the premarket process and improve discussions.

On Dec. 31, 2012, FDA released new Guidance for Industry on its Refuse to Accept Policy for 510(k) notifications.

Fiscal 2013 user fee payments by industry may be inaccessible to FDA if planned budget cuts take effect.

In recent months, FDA has been ramping up inspections of manufacturers who have pending filings for approval, notifications and other regulatory clearances.

On Dec. 22, 2010, the Government Accountability Office (GAO) released a report highlighting key differences in federal oversight standards among long-term acute care hospitals (LTACHs) and certain other classes of hospitals and skilled nursing facilities.

3 Boomerang Capital has announced a majority growth investment in Enjoin.

Adaptive Biotechnologies has announced it has completed a series C financing round and completed a newly created series D round of financing.

AirStrip, headquartered in San Antonio, Texas, is the developer of the AirStrip ONE enterprise-wide clinical mobility solution.

Amedica, headquartered in Salt Lake City, is a spinal and orthopedic implant and instrument company focused on silicon nitride ceramic technologies.

AMO Pharma Limited has announced it has secured $25 million in private equity financing.

Argosy Healthcare Partners (AHP) has announced the recapitalization of Nicklas Medical Staffing (NMS).

Ascend Partners has completed an equity investment in Rendr, according to a news release.

Atreca, based in Redwood City, California, is a privately held biotechnology company developing therapeutics drawn from human immune responses, including anti-cancer immune responses.

Benvenue Medical has announced it completed a $64 million round of financing.